People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Osmetech PLC | — | Biotechnology | Series A | $19.8M | $309.3M | 2009 |
Christopher Gleeson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Christopher Gleeson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Daryl J Faulkner | 1 | 2 |
| Jon Kayyem | 1 | 2 |
| Jon Faiz Kayyem | 1 | 2 |
| David Anthony Sandilands | 1 | 1 |
| David Sandilands | 1 | 1 |
| Daryl Faulkner | 1 | 1 |
| Gordon Bruce Kuenstor | 1 | 1 |
| Mark Paul Lappe | 1 | 1 |
| James Nicholas Gerald White | 1 | 1 |
| Gordon James Hall | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.